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Purpose: Oxidative stress has been proposed as a
contributor to pain in patients with myalgic
encephalomyelitis/chronic fatigue syndrome (ME/
CFS). During incremental exercise in patients with
ME/CFS, oxidative stress enhances sooner and
antioxidant response is delayed. We explored
whether oxidative stress is associated with pain
symptoms or pain changes following exercise, and
the possible relationships between oxidative stress
and parasympathetic vagal nerve activity in patients
with ME/CFS versus healthy, inactive controls.
Methods: The present study reports secondary
outcomes from a previous work. Data from 36
participants were studied (women with ME/CFS and
healthy controls). Subjects performed a submaximal12 www.paininmotion.be.
April 2019exercise test with continuous cardiorespiratory
monitoring. Levels of thiobarbituric acidereactive
substances (TBARSs) were used as a measure of
oxidative stress, and heart rate variability was used
to assess vagal activity. Before and after the exercise,
subjects were asked to rate their pain using a visual
analogic scale.
Findings: Signiﬁcant between-group differences in
pain at both baseline and following exercise were
found (both, P < 0.007). In healthy controls, pain
was signiﬁcantly improved following exercise
(P ¼ 0.002). No change in oxidative stress level after
exercise was found. Signiﬁcant correlation between
TBARS levels and pain was found at baseline
(r ¼ 0.540; P ¼ 0.021) and after exercise (r ¼ 0.524;Accepted for publication December 14, 2018
https://doi.org/10.1016/j.clinthera.2018.12.012
0149-2918/$ - see front matter
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Clinical TherapeuticsP ¼ 0.024) in patients only. No signiﬁcant correlation
between TBARS and heart rate variability at baseline
or following exercise was found in either group.
However, a signiﬁcant correlation was found
between exercise-induced changes in HRV and
TBARS in healthy controls (r ¼ −0.720; P ¼ 0.001).
Implications: Oxidative stress showed an
association with pain symptoms in people with ME/
CFS, but no exercise-induced changes in oxidative
stress were found. In addition, the change in
parasympathetic activity following exercise partially
accounted for the change in oxidative stress in
healthy controls. More research is required to further
explore this link. (Clin Ther. 2019;41:641e655) ©
2019 Elsevier Inc. All rights reserved.
Key words: Autonomic nervous system, Chronic
fatigue syndrome, Exercise, Oxidative stress, Pain.INTRODUCTION
Oxidative stress is the imbalance between an increased
production and/or reduced clearance of reactive
oxygen species that potentially leads to damaged
lipids, protein, and DNA.1 Oxidative stress may
induce deleterious changes, particularly to the CNS,
given the intrinsic high vulnerability of neurons and
glial cells to metabolic changes.2,3 Oxidative stress
covers an important role in synaptic plasticity and
many other mechanisms involved in nociceptive
modulation and central sensitization.4,5 Elevated levels
of spinal reactive oxygen species lead to peripheral and
central sensitization and alter nociception,6 resulting in
hyperalgesia mediated by both local and spinal
oxidant mechanisms. Nitric oxide also may induce
peripheral and central sensitization by reducing
receptor thresholds7 and may reduce the inhibitory
activity of the CNS, leading to central sensitization of
dorsal horn neurons.8 In line with these observations,
oxidative stress has also been associated with chronic
pain and proposed as a possible contributor to the
maintenance of pain symptoms.9
Central sensitizationddescribed as a state of
generalized hyper-responsiveness of the CNS to a
variety of stimulidhas been proposed as a key
mechanism in many chronic pain conditions,
including myalgic encephalomyelitis/chronic fatigue
syndrome (ME/CFS),10e12 a chronic condition in
which widespread pain is very common and often642reported as more disabling than fatigue itself.13
Indeed, patients with ME/CFS show hyper-
responsiveness to different stimuli and hyperalgesia to
electrical and mechanical stimulation when compared
to healthy controls.14
In addition, a cardinal symptom of people with ME/
CFS is postexertional malaiseda worsening of pain
and other symptoms in response to exercise, lasting up
to 48 h. While exercise normally induces hypoalgesic
effects in healthy subjects, quickly increasing pain
thresholds and improving subjective reports of pain
symptoms,15e17 people with ME/CFS actually show a
decrease in pain thresholds following exercise.18,19
The exact mechanisms underlying this lack of
exercise-induced hypoalgesia in ME/CFS are largely
unknown, as ME/CFS is heterogeneous in nature and
several mechanisms co-occur.20e22 However,
oxidative stress may reasonably be proposed as one
of the underlying mechanisms. Higher levels of
oxidative stress have been reported in people with
ME/CFS,23,24 and studies found that oxidative stress
occurs earlier during exercise in people with ME/CFS
compared to healthy controls.25,26 In addition, people
with ME/CFS present a delayed antioxidant response
following exercise.25,26
A second important mechanism that has been
proposed to explain the aforementioned exercise-
induced hyperalgesia in people with ME/CFS is the
alteration of the autonomic nervous system (ANS).27
Following exercise, patients with ME/CFS show higher
gene expression for receptors involved in ANS functions
compared to those in healthy controls, and these gene
concentrations are associated with pain symptoms.28 A
systematic review of the topic has shown that heart rate
variability (HRV)da commonly used and reliable
measure of ANS parasympathetic (vagal)
activity29,30ddiffers between people with ME/CFS and
controls.31 In another recent paper, we showed that
exercise-induced hyperalgesia was associated with a
reduced parasympathetic reactivation during the
recovery phase following exercise.32
Interestingly, preliminary evidence suggests that a
direct link might exist between ANS activity and
oxidative stress responses.33 Increased oxidative stress
in the rostral ventrolateral medulla in turn causes
excitation of the sympathetic branch.34 Similarly,
angiotensin-II receptor blockade induces both
inhibition of the ANS sympathetic branch and a
reduction in oxidative stress.34 In addition,Volume 41 Number 4
A. Polli et al.experimentally induced increased levels of oxidative
stress, in both animals and humans, will alter blood
ﬂow regulation and reduce muscle blood ﬂow during
exercise.35 Although the link between ANS and
oxidative stress appears to be clear, to the best of
our knowledge this association has never been
explored in patients with ME/CFS ordmore
generallydchronic pain.
In the present study, we aimed to explore whether
oxidative stress is associated with pain or with
changes in pain after exercise, and whether a possible
relationship exists between oxidative stress and ANS
functions in people with ME/CFS and healthy
controls. We believe that unravelling the mechanisms
associated with symptoms worsening following
exercise will help to identify the targets for future
treatments, therefore improving patients' care.
We hypothesized that oxidative stress is associated
with higher pain levels, and that the change in pain
symptoms induced by exercise is associated with the
change in oxidative stress in response to exercise. In
addition, we expected that oxidative stress and ANS
functions are also associated; that is, the higher the
level of oxidative stress, the lower the
parasympathetic activity in patients with ME/CFS.
METHODS
The present study reports additional analysis of a
subset of participants from a previous experimental
study32 from which oxidative stress measures were
available. While the previous work focused on
postexertional malaise and ANS responses, the
present work reports oxidative stress changes and
their relationship to pain.
Subjects
Eighteen patients with ME/CFS and 18 healthy
inactive (sedentary) controls participated in the study.
Patients' diagnosis, based on the criteria from the
1994 Centers for Disease Control and Prevention,36
was established by 2 physicians specializing in
internal medicine and with expertise regarding the
diagnosis and treatment of ME/CFS. Patients
were excluded if they reported any evidence of
other known neurologic, endocrine, immune, or
cardiovascular pathology.
Healthy controls were friends of either patients or
professionals involved in the research project and
volunteers who responded to advertisements. TheyApril 2019were included if they had no known signiﬁcant
pathology and had an inactive (sedentary) lifestyle.
Inactivity was deﬁned as having a seated occupation
and performing a maximum of 3 h/wk of moderate
physical activity.37
All participants were women aged between 18
and 65 years, Dutch speaking, and not pregnant,
breastfeeding, or <1 year postpartum. Only
women were included, as sex is an important
source of bias in exercise physiology and pain
studies,38e40 and because ME/CFS is
predominantly prevalent in women.41 Participants
were asked to refrain from consuming caffeine,
alcohol, and nicotine and to avoid physical
exertion on the day of the experiments. If possible,
patients were also asked to abstain from
medication that acts on the cardiovascular system,
the CNS, and the endocrine system in the 48 h
prior to the experiments.
The experiment protocol was approved by the ethics
committee at the University Hospital Brussels. All
participants provided written informed consent
before the start of the assessment.
Procedure
An initial familiarization session was scheduled for
at least 1 week before the start of the experimental
session, to inform participants about the procedures
and devices used during the experiment.
Demographic and clinical information was also
collected during this ﬁrst meeting.
Experiments took place in a quiet room with a
constant temperature between 21 C and 23 C. Pain
symptoms were assessed using self-reports. Prior to
exercise testing (10 min at rest) and during the
subsequent recovery period (again 10 min),
physiologic measures of autonomic function were
obtained. Measures of autonomic functions were
measured through ECG recording during 10 min of
quite supine lying. The Nexus-10 wireless and
portable telemetry data acquisition system (Mind
Media BV, Herten, the Netherlands) was used to
calculate the root mean square of successive
differences between NN intervals (RMSSD). Patients
wore an elastic belt around the chest, in which a
stretch-sensitive piezoelectric sensor was placed to
record respiratory peaks and respiratory rate.
A submaximal bicycle exercise test, known as
the aerobic power index, with continuous643
Clinical Therapeuticscardiorespiratory monitoring was then performed. The
aerobic power index is a standardized test shown to be
valid and reliable in both patients with ME/CFS and
healthy people.42 The detailed procedure for the
aerobic power index test can be found elsewhere.19
In summary, cycling started at a workload of 25
Watt/min, increased by 25 Watt/min until the patient
reached 75% of his or her age-predicted maximal
heart rate. Cycling rate was kept constant at 70
cycles/min.43 After the test, subjects were asked the
same self-reported measures of pain, which were
taken as the baseline measurements. Finally, subjects
were asked to lie down for 10 min, after which a
second blood sample was collected for measuring
oxidative stress responses to exercise.Outcomes Measures
Self-Reported Measures of Pain
Pain was assessed with 2 different tools. The ﬁrst is
the Bodily Pain Subscale of the 36-item Short Form
Health Survey (SF-36). It consists of 2 items that
assess pain intensity and the inﬂuence that pain had
on one's life during the previous 4 weeks.44 The 2
items give a general score ranging from 0 to 100,
with higher scores indicating more bodily pain. While
the previous study administered SF-36 postexercise as
well, we decided to not include that measure: SF-36
is speciﬁcally designed for assessing different health
domains in the previous 4 weeks, and it is not able to
detect quick symptom changes, such as preepost 1
bout of exercise. For this purpose, we indeed
preferred to use a visual analog scale (VAS) for
assessing bodily-pain intensity. The VAS comprised
100-mm horizontal lines, with the outer points
labeled as "no pain" and "unbearable pain." In
order to control for clinical features that might have
inﬂuenced our results, depression and anxiety were
assessed using the Hospital Anxiety and Depression
Scale,45 a validated and reliable tool for assessing
psychological distress in both patients and healthy
subjects.46Determination of Oxidative Stress
Two tubes of blood were collected 10 min before and
following the exercise test. Samples were stored at
ambient temperature for 1 h and were then
centrifuged for 10 min at 4000 rpm. The resulting
serum was stored at −80 C. Each sample was labeled644with a code so that the researcher in charge of the
analysis was blinded to the group allocation.
Biochemical analysis was performed at RED
Laboratories (Asse, Belgium). Oxidative stress was
evaluated by measurements of thiobarbituric
acidereactive substances (TBARSs) (OxiSelect TBARS
Assay Kit for malondialdehyde [MDA] quantitation;
Cell Biolabs, San Diego, California). TBARS is a well-
established assay for screening and monitoring lipid
peroxidationda generally accepted marker of
oxidative stress.47 The TBARS assay provides relevant
information concerning freeeradical activity in disease
states and measurement of the characteristics of many
antioxidant compounds.48,49Physiologic Measures of Autonomic Function
Data from the ECG recording were analyzed ofﬂine
with the BioSig toolbox in MatLab software (The
MathWorks, Natick, Massachusetts). The mean of
measurements over the 10-min periods were then used
for further analysis. From these measures, heart rate,
HRV, and the high-frequency (HF) component of
HRV (power range, 0.15e0.40 Hz) were calculated
after fast Fourier transformation. Further details
regarding raw data handling, artefact removal, and
analysis have been described in a previous article.32
Although international guidelines (1996)
recommend reporting the low-frequency (LF)
component of HRV and the LF/HF ratio,50 more
recent work questions the validity and reliability of
these measures.51e53 For this reason, we are not
reporting these parameters in the present article;
however, a detailed report of all autonomic measures
from this studydincluding both LF-HRV and the LF/
HF ratiodhas appeared previously.32 Here we report
measures of heart rate, HRV, and HF-HRV, expressed
as RMSSD, in order to link parasympathetic activity
with changes in oxidative stress.Statistical Analysis
We explored our data using between- and within-
group comparisons. Normality of the variables in
each group (patients and healthy controls) was
tested with the ShapiroeWilk test, and appropriate
descriptive statistics were calculated. Group
comparisons at baseline and following the exercise
test were examined using the independent-samples t
test or the ManneWhitney U test, according to theVolume 41 Number 4
A. Polli et al.results-of-normality analysis. The c2 test was used to
analyze categorical data. The paired-samples t test
or Wilcoxon signed rank test was performed to
analyze the effects of exercise in each group. The
Pearson or Spearman correlation analysis was used
to examine the relationship between self-reported
pain and TBARS measures. Correlation analyses
were also performed to identify associations between
ANS function and oxidative stress, as well as
between changes in parasympathetic activity (D-
HRV) and changes in oxidative stress levels (D-
MDA-TBARS). The signiﬁcance level was set at
0.05. All data were analyzed using SPSS version
23.0 (IBM, Armonk, NY).RESULTS
Subjects' Characteristics
Thirty-six subjects (18 patients with ME/CFS and
18 healthy inactive controls) completed the
assessment. Table I summarizes the demographic and
clinical characteristics of the groups. No statistically
signiﬁcant differences in age, body mass index,
anxiety, or depression at baseline were found. Pain
was scored signiﬁcantly higher on the SF-36 subscale
in patients with ME/CFS (P < 0.001). Patients with
ME/CFS also reported signiﬁcantly more pain than
did controls, as expressed on the VAS (P < 0.001).
No differences in either the level of oxidative stress
or the measures of ANS activity (ie, heart rate,
respiratory rate, HRV, and HF-HRV) at baseline
were found.Table I. Descriptive demographic and clinical characteris
drome/myalgic encephalomyelitis (ME/CFS) and
Characteristic ME/CF (n ¼
Age, y 40.9 (9.9)
BMI, kg/m2 26.7 (6.1)
Time since ME/CFS diagnosis, mo 75.7 (57.1
HADSeAnxiety 10.8 (5.6)
HADSeDepression 10.2 (5.4)
SF-36 bodily painy 53.4 (19.3
BMI ¼ body mass index; HADS ¼ Hospital Anxiety and Depressi
*Statistical signiﬁcance at P < 0.05 (ManneWhitney nonparame
yAssessed using a visual analog scale: 0 ¼ no pain to 100 ¼ wo
April 2019Effect of the Exercise Challenge
Within-group analysis revealed that pain (VAS)
improved following exercise only in healthy controls
(P ¼ 0.002), while it did not change in patients with
ME/CFS (P ¼ 0.393). Oxidative stress, measured
using MDA-TBARS level, did not change in response
to exercise in either group. In comparison, HRV and
HF-HRV (measured through RMSSD calculation)
decreased signiﬁcantly only in patients (P ¼ 0.039
and P ¼ 0.035, respectively). On exercise testing,
similar changes in the other measures (eg, heart rate
and respiratory rate), were found in both groups. The
effects of exercise on ANS measures (heart rate,
HRV, and HF-HRV) in ME/CFS were presented in a
recent article32 and are reported here only to provide
a clearer general picture of the results. Data are
summarized in Table II. Figures. 1 and 2 pair pain
and MDA-TBARS values, respectively, before and
after exercise in both healthy controls and in patients
with ME/CFS.
Associations Between Pain and Oxidative Stress
No correlations between MDA-TBARS and pain
symptoms were found in healthy subjects. On the
contrary, in patients with ME/CFS, MDA-TBARS
levels were related to VAS bodily pain, both at baseline
and after exercise (Table III). Figure 3 summarizes
visually the most relevant correlations between MDA-
TBARS levels and bodily pain in ME/CFS (baseline,
r ¼ 0.540 [P ¼ 0.021]; postexercise, r ¼ 0.524
[P ¼ 0.026]). Linear regression analysis revealed that
MDA-TBARS signiﬁcantly explained pain symptomstics at baseline in patients with chronic fatigue syn-
in healthy controls.
18) Controls (n ¼ 18) P
32.8 (14.2) 0.680
23.8 (4.5) 0.111
) e e
8.6 (7.1) 0.323
8.4 (12.2) 0.143
) 18.8 (20.4) <0.001*
on Scale; SF-36 ¼ 36-item Short-Form Health Survey.
tric test).
rst pain imaginable.
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Table II. Effects of submaximal aerobic exercise on pain, oxidative stress (D MDA-TBARS), and physiologic hart function before (pre) and after
(post) submaximal aerobic exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/CFS) and in healthy
controls. Data are given as mean (SD) unless otherwise noted.
Parameter ME/CFS (n ¼ 18) Controls (n ¼ 18) Pz
Pre Post D Py Pre Post D Py
Painx 50.11 (33.03) 51.03 (32.02) 0.917 (15.07) 0.393 15.80 (21.56) 5.16 (7.55) −10.64 (17.19) 0.002** 0.007*
Heart rate, bpm 71.20 (7.70) 73.90 (8.80) 3.06 (5.47) 0.053 73.74 (8.11) 73.84 (7.78) 0.35 (6.42) 0.983 0.191
Respiratory rate,
breaths/min
16.11 (4.27) 18.43 (3.74) 1.68 (2.06) 0.006* 15.63 (3.75) 16.67 (2.82) 1.03 (1.33) 0.001** 0.287
MDA-TBARS, mM/L 11.22 (2.66) 11.11 (2.69) −0.11 (2.02) 0.879 10.29 (2.30) 10.52 (2.07) 0.24 (1.67) 0.586 0.580
HRV, RMSSDk 28.04 (14.99) 21.70 (9.88) −6.34 (14.06) 0.039* 43.33 (31.93) 45.20 (29.93) 1.87 (26.44) 0.811 0.308
HF-HRV 178.69 (171.7) 97.11 (81.9) −81.58 (154.8) 0.035* 547.53 (810.8) 541.71 (600.2) −5.81 (539.6) 0.711 0.521
HF-HRV ¼ high frequency component of heart rate variability; MDA-TBARS ¼ malondialdehydeethiobarbituric acid reactive substances (this is a standardized
method to measure lipid peroxidation, a measure thought to reﬂect oxidative stress).
Statistically signiﬁcant differences: *P < 0.05, **P < 0.01.
yWilcoxon signed rank test for within-group analysis.
zManneWhitney U for between-group comparisons.
xAssessed using a visual analog scale: 0 ¼ no pain to 100 ¼ worst pain imaginable.
k Expressed as root mean square of successive differences.
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Figure 1. Mean (SD) pain scores before and after submaximal aerobic exercise in patients with chronic fatigue
syndrome/myalgic encephalomyelitis (ME/CFS) and healthy controls.
A. Polli et al.inMC/CFS (before exercise,R2¼0.259 [P¼0.03]; after
exercise, R2 ¼ 0.254 [P ¼ 0.03]).
Regarding the SF-36 bodily pain score and MDA-
TBARS levels, no signiﬁcant correlations were found.
The D-MDA-TBARS from baseline to postexercise
did not correlate with the changes in pain measures
(Table III).
Associations Between Oxidative Stress and ANS
Activity
No association between MDA-TBARS and ANS
activity was found in either group at baseline or after
the exercise challenge. In the healthy-controls group,
strong associations were found between D-MDA-
TBARS levels and D-HRV. More speciﬁcally, the
exercise-induced decrease in MDA-TBARS level was
strongly associated with the increases in HRVApril 2019(r ¼ −0.720; P ¼ 0.001) and HF-HRV (r ¼ −0.674;
P ¼ 0.002). Linear regression analysis demonstrated
that the change in parasympathetic activity may
explain over 36% of the change in MDA-TBARS
levels (R2 ¼ 0.366; P ¼ 0.008). Also, D-MDA-
TBARS was correlated with D-HRV (r ¼ −0.522;
P ¼ 0.026). No such correlations were found in the
ME/CFS group. Table III shows the aforementioned
correlations. The most relevant associations are
presented in Figure 4.DISCUSSION
In the present study, we aimed to investigate possible
associations between oxidative stress and pain
symptoms in healthy subjects and patients with ME/
CFS, and to assess whether oxidative stress levels and
ANS parasympathetic (vagal) activity are linked. We647
Figure 2. Mean (SD) levels of malondialdehydeethiobarbituric acid reactive substances (MDA-TBARS) before
and after submaximal aerobic exercise in patients with chronic fatigue syndrome/myalgic encepha-
lomyelitis (ME/CFS) and healthy controls.
Clinical Therapeuticsset up a design in which subjects underwent a
submaximal exercise test and we recorded pain
symptoms, oxidative stress level, and ANS activity
before and after the test.
Our results only partially conﬁrm results from the
available literature. First, we did not ﬁnd higher
levels of oxidative stress in ME/CFS and chronic pain
when compared to healthy subjects at baseline, as
previously reported.6,14,23 A possible explanation
might be that, in the present study, we controlled for
physical activity levels, enrolling only sedentary
healthy controls. Studies focusing on oxidative stress648in patients with chronic pain rarely account for
physical activity. However, patients are likely less
active than healthy subjects.54e56 Our results suggest
that lower physical activity may account for higher
oxidative stress levels and should be assessed in
patients with chronic pain. Our results are in line
with those shown by Jammes et al,26 who did not
ﬁnd any increase in oxidative stress at baseline in
patients without acute infection or a high level of
physical stress.
Second, exercise did not induce any change in
oxidative stress levels. However, oxidative stressVolume 41 Number 4
Table III. Correlation analysis between pain, oxidative stress (MDA-TBARS), and parasympathetic activity
(HRV) before (pre) and after (post) submaximal aerobic exercise in patients with chronic fatigue
syndrome/myalgic encephalomyelitis (ME/CFS) and healthy controls. The table reports nonpara-
metric correlation both before and after exercise, and between the preepost changes (D).
Parameter Pre Post D
r P r P r P
ME/CFS
Painy
MDA-TBARS, mM/L 0.540* 0.021* 0.524* 0.026* 0.026 0.917
HRV 0.443 0.065 0.116 0.648 0.351 0.154
HF-HRV 0.314 0.204 0.046 0.855 0.260 0.298
MDA-TBARS, mM/L
HRV 0.251 0.315 0.253 0.311 0.107 0.671
HF-HRV 0.173 0.491 0.349 0.156 −0.080 0.754
HRVz
HF-HRV 0.917** 0.001** 0.922** 0.001** 0.901** 0.001**
Controls
Painy
MDA-TBARS, mM/L 0.179 0.476 0.119 0.638 0.076 0.765
HRV, RMSSD 0.070 0.783 0.065 0.798 0.001 0.997
HF-HRV −0.061 0.811 0.010 0.970 −0.078 0.759
MDA-TBARS, mM/L
HRV, RMSSD 0.073 0.773 0.401 0.099 −0.720** 0.001**
HF-HRV 0.145 0.570 0.443 0.066 −0.674** 0.002**
HRVz
HF-HRV 0.975** 0.001** 0.957** 0.001** 0.973** 0.001**
HF-HRV ¼ high-frequency component of HRV; MDA-TBARS ¼ malondialdehydeethiobarbituric acid reactive substances (this
is a standardized method to measure lipid peroxidation, a measure thought to reﬂect oxidative stress); HRV ¼ heart rate
variability.
Statistically signiﬁcant differences: *P < 0.05, **P < 0.005.
yAssessed using a visual analog scale: 0 ¼ no pain to 100 ¼ worst pain imaginable.
z Expressed as root mean square of successive differences.
A. Polli et al.responses to exercise might be mediated by exercise
intensity. A maximal exercise test seems to induce
clear changes in TBARS level in patients with ME/
CFS.9 It is possible that the submaximal exercise test
we used was not sufﬁciently intense to induce an
oxidative stress response.
However, exercise was intense enough to exert a
hypoalgesic effect in healthy subjects, conﬁrming
ﬁndings from the existing literature.15,19,32,57,58
Patients with ME/CFS, in contrast, did not show
hypoalgesia following exercise.19,22,34,59 Oxidative
stress was consistently associated with patients' painApril 2019symptoms both prior to and following exercise in our
study, explaining >25% of patients' pain.
The mechanisms underlying this exercise-induced
hypoalgesia have been explored but are still not fully
understood.22,25,58,59 We found very interesting results
when exploring the association between
parasympathetic activity and oxidative stress and we
therefore propose that exercise-induced oxidative stress
responses might be ﬁnely regulated by parasympathetic
activity. We have already shown that HRV is lower in
patients with ME/CFS31 and that it is further decreased
in patients with ME/CFS but not in healthy subjects.32649
Figure 3. Associations between pain symptoms (assessed using a visual analog scale: 0 ¼ no pain to 100 ¼ worst pain imaginable) and oxidative
stress levels before and after submaximal aerobic exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis (ME/
CFS) and healthy controls. Only patients showed statistically signiﬁcant correlations (B and D).
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Figure 4. Associations between exercise-induced changes in parasympathetic activity (D HRV) and changes in
Oxidative stress levels (D MDA-TBARS) in patients with chronic fatigue syndrome/myalgic enceph-
alomyelitis (ME/CFS) and healthy controls. HRV ¼ heart rate variability; MDA-
TBARS ¼ malondialdehydeethiobarbituric acid reactive substances (this is a standardized method to
measure lipid peroxidation, a measure thought to reﬂect oxidative stress); RMSSD ¼ root mean
square of successive differences.
A. Polli et al.
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Clinical TherapeuticsNow we have found that exercise-induced changes
in parasympathetic activity were strongly associated
with changes in oxidative stress in healthy people,
and that changes in the vagal activity can explain up
to 36% of the change in oxidative stress level. In
particular, the decrease in oxidative stress was
associated with increases in both HRV and HF-HRV
following exercise. Increased HRV reﬂects an increase
in parasympathetic (vagal) activity.60 That is, the
more the increase in parasympathetic activity during
exercise, the more the reduction in oxidative stress
levels. This ﬁnding supports those from animal and
preliminary human studies, suggesting an interplay
between oxidative stress and the ANS,34,35 and calls
for further research on this potentially very relevant
link. This association was found only in healthy
controls, suggesting that it might be a normal
physiologic response that may be disrupted in
patients. Unfortunately, we failed to ﬁnd an
association between pain reduction and oxidative
stress changesdwhich would have made our results
more coherent. However, we did not take any
measure of antioxidant capacity, which might be
more relevant than pro-oxidant products when
moderate exercise is employed.61
Our data should be interpreted with caution. First,
oxidative stress was associated with pain in patients
with ME/CFS, but exercise did not induce a signiﬁcant
change in oxidative levels. Second, the association
between oxidative stress and parasympathetic activity
does not refer to postexertional values, but rather the
(preepost) changes induced by the exercise bout.
However, it is also true that symptoms worsening in
people with ME/CFS are speciﬁcally related to physical
exertion, so that exploring exercise-induced changes is
potentially crucial to understanding their condition.
Finally, we included measures of parasympathetic
activity only: HF-HRV and RMSSD. HRV measures
reﬂecting sympathetic activity such as LF-HRV and
the LF/HF ratio, have been extensively criticized and
deemed unreliable,51e53 and we decided not to include
them. Other measures have been recently proposed to
assess sympathetic activity, in particular blood
pressure variability.62e64 A link between blood
pressure and pain sensitivity has been found in patients
with chronic pain.65 Blood pressure changes have been
linked to exercise-induced hypoalgesia66dsuggesting a
relevant role for the baroreceptor reﬂex.67 However,
beat-to-beat blood pressure registration is required to652assess this relationship,68 something that our devices
could not measure.
In addition, othermechanisms could play a role in the
pathophysiology ofME/CFS. Immune system alteration
and inﬂammation are deﬁnitely major ones. Evidence
shows that elevated levels of inﬂammatory cytokines
released by degenerative peripheral tissues and
immune cells can be part of the pathophysiology of
ME/CFS as well as other persistent and widespread
pain syndromes, such as ﬁbromyalgia.69e72 However,
whether these mechanisms play a role in exercise-
induced fatigue or hyperalgesia has yet to be
investigated in detail. To date, available data on the
link between immune system changes and
postexertional malaise are inconclusive.22 Future
research exploring the immune system response is
warranted, as it might be of outstanding clinical interest.
CONCLUSIONS
Trying to translate basic knowledge into clinical
research is always challenging, especially when using
indirect measures of complex phenomena such as
ANS activity and oxidative stress. However, we
believe our results are interesting and exciting
insights into the as-yet underexplored link. While we
found no exercise-induced changes in oxidative stress,
we found consistent associations between pain
symptoms and oxidative stress in patients with ME/
CFS. On the contrary, there was a strong association
between exercise-induced changes in ANS and
oxidative stress changes in healthy controls. The
more that parasympathetic activity increases
following exercise, the greater the reduction in
oxidative stress. We suggest that vagal activity exerts
regulatory actions on oxidative stress during exercise.
Patients with ME/CFS and other chronic pain
conditions might lack this control, and that might
account for the lack of exercise-induced hypoalgesia
that is often found in these patients. Exploring these
mechanisms could potentially lead to helpful and
innovative treatments for chronic pain.
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